1.480SEK-3.27%Mkt Cap: 89.32M SEKP/E: —Last update: 2026-05-13
aXichem AB, a biotechnology company, engages in the development of natural analogue ingredients in Sweden. The company offers aXivite, a natural analogue capsaicin solution for a range of dietary health applications; aXi…
Industry Peers
Specialty Chemicals101.71BEURP/E 29.0
38.19BTRY—
25.64BSEKP/E 13.9
19.99BTRYP/E 3310.6
16.73BTRY—
14.60BTRY—
14.51BNOKP/E 26.3
10.31BEURP/E 41.4
loading…
Indicators:|
Key Statistics
Valuation
P/E (Trailing)—
P/E (Forward)—
PEG—
P/B1.68
P/S4.84
EV/EBITDA-7.17
EV/Revenue4.90
EPS (TTM)-0.30
EPS (Forward)—
Cash Flow & Leverage
FCF Yield-10.89%
FCF Margin-52.74%
Operating CF-11.35M SEK
CapEx (TTM)—
Net Debt/EBITDA-0.13
Net Debt1.64M SEK
Technical
SMA 501.410 (+5.0%)
SMA 2002.182 (-32.2%)
Beta-0.71
S&P 52W Chg24.23%
Avg Vol (30d)46.28K
Avg Vol (10d)49.31K
Technical Indicators
RSI (14)57.0
MACD0.0215
MACD Signal-0.0030
MACD Hist.+0.0245
BB Upper1.549 SEK
BB Middle1.380 SEK
BB Lower1.211 SEK
BB Width24.48%
ATR (14)0.1018 SEK
Vol Ratio (20d)0.17x
52W Range
1.13512% of range4.100
52W High4.100 SEK
52W Low1.135 SEK
Profitability
Gross Margin49.23%
EBITDA Margin-68.28%
Profit Margin-95.59%
Oper. Margin-134.97%
ROE-33.36%
ROA-28.86%
Revenue Growth176.30%
Earnings Growth—
Balance Sheet
Debt/Equity0.09
Current Ratio1.84
Quick Ratio0.87
Book Value/Sh0.8940 SEK
Cash/Share0.0520 SEK
Dividends
Fwd Div Rate—
Trail. Div Rate0.0000 SEK
Div. Yield—
5Y Avg Yield—
Payout Ratio0.00%
Ex-Div Date—
Pay Date—
Ownership
Shares Out.59.55M
Float41.87M
Insiders21.38%
Institutions28.79%
Analyst Consensus
Rating—
Target (Mean)—
Target Range—
# Analysts—
Company
Market Cap89.32M SEK
Enterprise Value90.34M SEK
Revenue (TTM)18.45M SEK
Gross Profit9.08M SEK
Net Income (TTM)-17.63M SEK
Revenue/Share0.3120 SEK
Fiscal Year EndDec 2025
MR QuarterDec 2025
Employees7
Last Price1.480 SEK
CountrySE
SectorBasic Materials
IndustrySpecialty Chemicals
ISIN—